Point72 Asset Management L.P. boosted its stake in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 144.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,059,791 shares of the health services provider's stock after acquiring an additional 1,216,263 shares during the period. Point72 Asset Management L.P. owned 1.59% of Select Medical worth $71,825,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of SEM. Janus Henderson Group PLC grew its holdings in Select Medical by 14.7% during the 3rd quarter. Janus Henderson Group PLC now owns 54,021 shares of the health services provider's stock valued at $1,883,000 after buying an additional 6,922 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Select Medical during the 3rd quarter valued at approximately $290,000. BNP Paribas Financial Markets grew its holdings in shares of Select Medical by 141.0% in the third quarter. BNP Paribas Financial Markets now owns 26,720 shares of the health services provider's stock valued at $932,000 after purchasing an additional 15,635 shares in the last quarter. Quantbot Technologies LP bought a new stake in Select Medical in the third quarter worth $232,000. Finally, Loomis Sayles & Co. L P purchased a new stake in Select Medical during the third quarter valued at $9,710,000. 89.48% of the stock is currently owned by institutional investors.
Select Medical Trading Down 0.3 %
Shares of SEM stock traded down $0.07 on Thursday, reaching $20.45. 1,654,049 shares of the company's stock were exchanged, compared to its average volume of 668,844. The company's fifty day simple moving average is $32.96 and its 200 day simple moving average is $34.33. Select Medical Holdings Co. has a 52 week low of $19.82 and a 52 week high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market capitalization of $2.65 billion, a PE ratio of 9.56, a P/E/G ratio of 0.41 and a beta of 1.43.
Select Medical (NYSE:SEM - Get Free Report) last released its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period last year, the company earned $0.46 earnings per share. As a group, analysts forecast that Select Medical Holdings Co. will post 1.97 EPS for the current year.
Select Medical Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were given a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date was Wednesday, November 13th. Select Medical's dividend payout ratio (DPR) is presently 23.36%.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. Bank of America assumed coverage on shares of Select Medical in a report on Tuesday, August 20th. They issued a "buy" rating and a $42.00 target price on the stock. StockNews.com raised Select Medical from a "hold" rating to a "buy" rating in a research note on Tuesday. Benchmark lowered Select Medical from a "buy" rating to a "hold" rating in a research note on Monday, November 25th. Finally, Royal Bank of Canada boosted their target price on Select Medical from $40.00 to $47.00 and gave the company an "outperform" rating in a research report on Monday, November 4th.
View Our Latest Research Report on SEM
Insider Activity
In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the firm's stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now directly owns 22,000 shares in the company, valued at $463,980. This trade represents a 59.26 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 19.14% of the company's stock.
Select Medical Company Profile
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Read More
Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.